immunologic factors

Preferred Label : immunologic factors;

MeSH definition : Biologically active substances whose activities affect or play a role in the functioning of the immune system.;

MeSH synonym : factors, immunological; factors, immune; immune factors; factors, immunologic; immunological factors; Immune Factor; Factor, Immune; Immunological Factor; Factor, Immunological;

Related MeSH term : biological response modifiers; immunomodulators; Biomodulators; Modifiers, Biological Response; Response Modifiers, Biological; Immunomodulator; Biological Response Modifier; Modifier, Biological Response; Response Modifier, Biological; Biomodulator;

Wikipedia link : https://en.wikipedia.org/wiki/Biological response modifiers;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D007155;

UMLS CUI

C0021054;

ATC code(s)
- antineoplastic and immunomodulating agents [ATC Code]
- immunoglobulins, normal human [ATC Code]
- immunoglobulins, normal human, for extravascular adm. [ATC Code]
- immunoglobulins, normal human, for intravascular adm. [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Biological Agent [NCIt concept]
- Biological Therapy [NCIt concept]
- Immunologic Factor [UMLS semantic type]
- Immunomodulator (disposition) [SNOMED CT concept]
- Immunomodulators [PASCAL theme]
- Immunoregulation [NCIt concept]
- Immunotherapeutic Agent [NCIt concept]
- Product containing immunomodulator (product) [SNOMED CT concept]
- Substance with immunomodulator mechanism of action (substance) [SNOMED CT concept]
- immune modulation [Blood Transfusion thesaurus concept]
- immunomodulation [COVID-19 Thesaurus concept]
- immunomodulation [Artificial nutrition thesaurus concept]
- immunomodulator [COVID-19 Thesaurus concept]
CISMeF manual mappings
- Immunologic agent (substance) [SNOMED CT concept]
Indexing information
- (4-formyl-9-methoxy-5-methyl-naphtho(2,3-b)furan-3-yl)methyl acetate [MeSH Supplementary Concept]
- 1-O-beta-D-glucopyranosyl-(2S,2'R,3R,3'E,4E,8E)-N-(2'-hydroxy-3'-hexadecenoyl)-9-methyl-4,8-icosadien-1,3-diol [MeSH Supplementary Concept]
- 14-desoxo-3alpha,5alpha,7beta,10,15beta-O-pentaacetyl-14beta-O-butanoyl-10,18-dihydromyrinsol [MeSH Supplementary Concept]
- 14-desoxo-3beta,5alpha,7beta,10,15beta-O-pentaacetyl-14alpha-O-benzoyl-10,18-dihydromyrinsol [MeSH Supplementary Concept]
- 3,5,10,14,15-pentaacetyl-8-isobutanoyl-cyclomyrsinol [MeSH Supplementary Concept]
- 3-nicotinyl-5,10,14,15-tetraacetyl-8-(2',3'-dimethylbutanoyl)cyclomyrsinol [MeSH Supplementary Concept]
- 3-phenyl-4,5-dihydro-5-isoxazole acetic acid [MeSH Supplementary Concept]
- ACA (immunomodulatory protein), antrodia camphorata [MeSH Supplementary Concept]
- AMG623 peptibody [MeSH Supplementary Concept]
- CCDC86 protein, human [MeSH Supplementary Concept]
- DIMS0150 [MeSH Supplementary Concept]
- FL-6 peptide [MeSH Supplementary Concept]
- bifivir [MeSH Supplementary Concept]
- cyclic(G(2'-5')pA(3'-5')p) [MeSH Supplementary Concept]
- diazochromone [MeSH Supplementary Concept]
- echinaforce [MeSH Supplementary Concept]
- fibroblast-derived tumor cytotoxic factor [MeSH Supplementary Concept]
- frenatin 2 protein, discoglossus sardus [MeSH Supplementary Concept]
- guadecitabine [MeSH Supplementary Concept]
- meta-azochromone [MeSH Supplementary Concept]
- para-azochromone [MeSH Supplementary Concept]
- plasticin-L1 peptide, leptodactylus laticeps [MeSH Supplementary Concept]
- sargramostim [MeSH Supplementary Concept]
- wilforidine [MeSH Supplementary Concept]
Metaterm(s)
- allergy and immunology [CISMeF Metaterm]
Record concept(s)
- biological response modifiers [MeSH concept]
- immunologic factors [MeSH concept]
- immunomodulators [MeSH concept]
See also
- molecular mechanisms of pharmacological action [MeSH Descriptor]
- receptors, immunologic [MeSH Descriptor]
See also (suggested by CISMeF)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
Substance(s)
- 15-deoxy-delta(12,14)-prostaglandin J2 [MeSH Supplementary Concept]
- 192 IgG-saporin [MeSH Supplementary Concept]
- 8-chloro-cyclic adenosine monophosphate [MeSH Supplementary Concept]
- Ado-Trastuzumab Emtansine [MeSH Descriptor]
- Alefacept [MeSH Descriptor]
- BACH 250-rGel [MeSH Supplementary Concept]
- Brentuximab Vedotin [MeSH Descriptor]
- Bz-423 [MeSH Supplementary Concept]
- CD4 immunoadhesins [MeSH Descriptor]
- CD79 Antigens [MeSH Descriptor]
- Gemtuzumab [MeSH Descriptor]
- HIV antibodies [MeSH Descriptor]
- HTLV-I antibodies [MeSH Descriptor]
- HTLV-II antibodies [MeSH Descriptor]
- Heptavalent Pneumococcal Conjugate Vaccine [MeSH Descriptor]
- Inotuzumab Ozogamicin [MeSH Descriptor]
- Lenalidomide [MeSH Descriptor]
- Long-Acting thyroid stimulator [MeSH Descriptor]
- Membrane Cofactor Protein [MeSH Descriptor]
- Natalizumab [MeSH Descriptor]
- O-deacetyl platelet activating factor [MeSH Supplementary Concept]
- OX7-saporin [MeSH Supplementary Concept]
- Ranibizumab [MeSH Descriptor]
- Rho(D) immune globulin [MeSH Descriptor]
- Rituximab [MeSH Descriptor]
- SSP-SAP fusion protein, recombinant [MeSH Supplementary Concept]
- afelimomab [MeSH Supplementary Concept]
- anaphylatoxins [MeSH Descriptor]
- anti-VAChT antibody-saporin conjugate immunotoxin [MeSH Supplementary Concept]
- antibodies [MeSH Descriptor]
- antibodies, anti-idiotypic [MeSH Descriptor]
- antibodies, anticardiolipin [MeSH Descriptor]
- antibodies, antineutrophil cytoplasmic [MeSH Descriptor]
- antibodies, antinuclear [MeSH Descriptor]
- antibodies, antiphospholipid [MeSH Descriptor]
- antibodies, archaeal [MeSH Descriptor]
- antibodies, bacterial [MeSH Descriptor]
- antibodies, bispecific [MeSH Descriptor]
- antibodies, blocking [MeSH Descriptor]
- antibodies, fungal [MeSH Descriptor]
- antibodies, helminth [MeSH Descriptor]
- antibodies, heterophile [MeSH Descriptor]
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, neoplasm [MeSH Descriptor]
- antibodies, phospho-specific [MeSH Descriptor]
- antibodies, protozoan [MeSH Descriptor]
- antibodies, viral [MeSH Descriptor]
- antigen-antibody complex [MeSH Descriptor]
- antistreptolysin [MeSH Descriptor]
- antitoxins [MeSH Descriptor]
- antivenins [MeSH Descriptor]
- autoantibodies [MeSH Descriptor]
- bence jones protein [MeSH Descriptor]
- bivatuzumab mertansine [MeSH Supplementary Concept]
- botulinum antitoxin [MeSH Descriptor]
- cantuzumab mertansine [MeSH Supplementary Concept]
- complement C1 [MeSH Descriptor]
- complement C1q [MeSH Descriptor]
- complement C1r [MeSH Descriptor]
- complement C1s [MeSH Descriptor]
- complement C2 [MeSH Descriptor]
- complement C2a [MeSH Descriptor]
- complement C2b [MeSH Descriptor]
- complement C3 [MeSH Descriptor]
- complement C3 convertase, alternative pathway [MeSH Descriptor]
- complement C3 convertase, classical pathway [MeSH Descriptor]
- complement C3-C5 convertases [MeSH Descriptor]
- complement C3-C5 convertases, alternative pathway [MeSH Descriptor]
- complement C3-C5 convertases, classical pathway [MeSH Descriptor]
- complement C3a [MeSH Descriptor]
- complement C3b [MeSH Descriptor]
- complement C3c [MeSH Descriptor]
- complement C3d [MeSH Descriptor]
- complement C4 [MeSH Descriptor]
- complement C4a [MeSH Descriptor]
- complement C4b [MeSH Descriptor]
- complement C5 [MeSH Descriptor]
- complement C5 convertase, alternative pathway [MeSH Descriptor]
- complement C5 convertase, classical pathway [MeSH Descriptor]
- complement C5a [MeSH Descriptor]
- complement C5a, des-Arginine [MeSH Descriptor]
- complement C5b [MeSH Descriptor]
- complement C6 [MeSH Descriptor]
- complement C7 [MeSH Descriptor]
- complement C8 [MeSH Descriptor]
- complement C9 [MeSH Descriptor]
- complement activating enzymes [MeSH Descriptor]
- complement factor B [MeSH Descriptor]
- complement factor D [MeSH Descriptor]
- complement membrane attack complex [MeSH Descriptor]
- complement system proteins [MeSH Descriptor]
- cryoglobulins [MeSH Descriptor]
- cysteinyl-leukotriene [MeSH Supplementary Concept]
- deltaretrovirus antibodies [MeSH Descriptor]
- deoxypodophyllotoxin [MeSH Supplementary Concept]
- diphtheria antitoxin [MeSH Descriptor]
- eosinophil cationic protein [MeSH Descriptor]
- eosinophil granule proteins [MeSH Descriptor]
- eosinophil major basic protein [MeSH Descriptor]
- eosinophil peroxidase [MeSH Descriptor]
- eosinophil-derived neurotoxin [MeSH Descriptor]
- etrolizumab [MeSH Supplementary Concept]
- felzartamab [MeSH Supplementary Concept]
- fructose-1,6-diphosphate [MeSH Supplementary Concept]
- gamma-globulins [MeSH Descriptor]
- hepatitis A antibodies [MeSH Descriptor]
- hepatitis C antibodies [MeSH Descriptor]
- hepatitis antibodies [MeSH Descriptor]
- hepatitis b antibodies [MeSH Descriptor]
- immune sera [MeSH Descriptor]
- immunoconglutinins [MeSH Descriptor]
- immunoconjugates [MeSH Descriptor]
- immunoglobulin A [MeSH Descriptor]
- immunoglobulin A, secretory [MeSH Descriptor]
- immunoglobulin D [MeSH Descriptor]
- immunoglobulin G [MeSH Descriptor]
- immunoglobulin J-chains [MeSH Descriptor]
- immunoglobulin M [MeSH Descriptor]
- immunoglobulin allotypes [MeSH Descriptor]
- immunoglobulin alpha-chains [MeSH Descriptor]
- immunoglobulin constant regions [MeSH Descriptor]
- immunoglobulin delta-chains [MeSH Descriptor]
- immunoglobulin e [MeSH Descriptor]
- immunoglobulin epsilon-chains [MeSH Descriptor]
- immunoglobulin fab fragments [MeSH Descriptor]
- immunoglobulin fc fragments [MeSH Descriptor]
- immunoglobulin fragments [MeSH Descriptor]
- immunoglobulin gamma-chains [MeSH Descriptor]
- immunoglobulin gm allotypes [MeSH Descriptor]
- immunoglobulin heavy chains [MeSH Descriptor]
- immunoglobulin idiotypes [MeSH Descriptor]
- immunoglobulin isotypes [MeSH Descriptor]
- immunoglobulin joining region [MeSH Descriptor]
- immunoglobulin kappa-chains [MeSH Descriptor]
- immunoglobulin km allotypes [MeSH Descriptor]
- immunoglobulin lambda-chains [MeSH Descriptor]
- immunoglobulin light chains [MeSH Descriptor]
- immunoglobulin mu-chains [MeSH Descriptor]
- immunoglobulin subunits [MeSH Descriptor]
- immunoglobulin variable region [MeSH Descriptor]
- immunoglobulins [MeSH Descriptor]
- immunoglobulins, intravenous [MeSH Descriptor]
- immunoglobulins, thyroid-stimulating [MeSH Descriptor]
- immunotoxin HA22 [MeSH Supplementary Concept]
- immunotoxins [MeSH Descriptor]
- insulin antibodies [MeSH Descriptor]
- interferon-alpha [MeSH Descriptor]
- interferon-beta [MeSH Descriptor]
- isoantibodies [MeSH Descriptor]
- keratinocyte-derived chemokines [MeSH Supplementary Concept]
- lexatumumab [MeSH Supplementary Concept]
- lorvotuzumab mertansine [MeSH Supplementary Concept]
- lupus coagulation inhibitor [MeSH Descriptor]
- mannose-binding protein-associated serine proteases [MeSH Descriptor]
- myeloma proteins [MeSH Descriptor]
- ocrelizumab [MeSH Supplementary Concept]
- opsonin proteins [MeSH Descriptor]
- paraproteins [MeSH Descriptor]
- plantibodies [MeSH Descriptor]
- pomalidomide [MeSH Supplementary Concept]
- properdin [MeSH Descriptor]
- pyroglobulins [MeSH Descriptor]
- reagins [MeSH Descriptor]
- receptors, antigen, B-Cell [MeSH Descriptor]
- rheumatoid factor [MeSH Descriptor]
- sargramostim [MeSH Supplementary Concept]
- secretory component [MeSH Descriptor]
- sifalimumab [MeSH Supplementary Concept]
- tetanus antitoxin [MeSH Descriptor]
- tuftsin [MeSH Descriptor]
- vaccines [MeSH Descriptor]
- visilizumab [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Immunologic substance (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients